Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F3 | P13726 | 3/20 | 0.49 |
| ▸ | MTTP | P55157 | 14/20 | 0.47 |
| ▸ | APOB | P04114 | 4/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7610756 | 0.84 | APOB (0.51) | MTTPAPOBL3MBTL1 | |
| SCHEMBL7605547 | 0.84 | F3 (0.53) | F3MTTPAPOB | |
| SCHEMBL7610500 | 0.82 | APOB (0.51) | MTTPAPOBL3MBTL1 | |
| SCHEMBL7605535 | 0.81 | L3MBTL1 (0.51) | MTTPAPOBL3MBTL1 | |
| SCHEMBL7605815 | 0.77 | APOB (0.63) | MTTPAPOBL3MBTL1 | |
| SCHEMBL7609278 | 0.77 | ALDH1A1 (0.58) | MTTPAPOB | |
| SCHEMBL7608643 | 0.75 | APOB (0.55) | F3MTTPAPOBL3MBTL1 | |
| SCHEMBL6799012 | 0.75 | APOB (0.66) | MTTPAPOBL3MBTL1 | |
| SCHEMBL7612153 | 0.75 | MTTP (0.54) | MTTP | |
| SCHEMBL7605511 | 0.75 | APOB (0.56) | MTTPAPOBL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020032238-A1 | Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020032238-A1 | Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments | MTTP, CETP, FABP1 | F3 578/4885MTTP 1/4885APOB 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.